Nanobodies News and Research

RSS
Nanobody Nano-85 holds promise for detection of noroviral RNA

Nanobody Nano-85 holds promise for detection of noroviral RNA

Researchers uncover 3D structure of neuroreceptor

Researchers uncover 3D structure of neuroreceptor

Researchers identify important steps to understand mechanisms underlying pathogenic effect of prions

Researchers identify important steps to understand mechanisms underlying pathogenic effect of prions

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Novel anti-cancer drug conjugates to be evaluated by Ablynx and Spirogen

Novel anti-cancer drug conjugates to be evaluated by Ablynx and Spirogen

Scientists open new front against cause of sleeping sickness

Scientists open new front against cause of sleeping sickness

Scientists image structure of bacterium protein coat

Scientists image structure of bacterium protein coat

VCAM1 nanobodies can effectively visualize atherosclerotic lesions

VCAM1 nanobodies can effectively visualize atherosclerotic lesions

Camel blood can help scientists fight against cancer

Camel blood can help scientists fight against cancer

Breast cancer patients can benefit from new nanobodies

Breast cancer patients can benefit from new nanobodies

New strategy against Botulinum toxin

New strategy against Botulinum toxin

Merck Serono and Ablynx to jointly develop nanobodies

Merck Serono and Ablynx to jointly develop nanobodies

Domantis successful in patent opposition

Domantis successful in patent opposition

Nanobodies herald a new era in cancer therapy

Nanobodies herald a new era in cancer therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.